MSK’s team for treating benign blood disorders includes board-certified hematologists, clinical nurses, and nurse practitioners. Our sole focus is to diagnose and address these conditions before they become life-threatening. The hematology team collaborates with medical oncologists, radiation oncologists, surgeons, and other staff at Memorial Sloan Kettering. We identify people who may be at risk of blood-related complications. We develop a coordinated treatment plan for each individual.

When treatment for a blood clot, bleeding disorder, or anemia is necessary, our team works aggressively to reverse the problem. Then you can safely return to your cancer treatment. Our specially trained nurse practitioners and hematologists monitor your care throughout the course of your cancer treatment.

Our team is conducting scientific research to improve strategies for preventing blood clots, thrombocytopenia, and other noncancerous blood disorders that are caused by cancer or chemotherapy. Our hematologists also have expertise in caring for people who have blood disorders that are not caused by cancer or cancer treatment.

Select from the list below to learn more about our benign blood disorder specialists, their education, training, board certifications, current publications, and specific areas of clinical expertise.